UCB :: Business Development

Partnering with leaders

We recognise that developing and commercialising innovative therapies is not always achieved alone but as a result of partnerships. That is why we have teamed up with partners from the pharmaceutical industry.

Lorem

News 2009 ›

Business Development & Licensing

Areas of interestUCB is seeking to expand its pipeline and product portfolio with innovative products that will treat patients suffering from severe diseases. Our areas of interest include: CNS and Immunology.
Strategic partnersUCB's strategic partnerships range from joint discovery, joint development, commercialisation and manufacturing agreements with a wide range of small to large parties.
Case studiesUCB has successfully partnered with leaders in the pharmaceutical industry as Pfizer, Jazz Pharmaceuticals, Immunomedics, and Wilex.

Contact Business Development

Business Development

Events 2010

Pharmaceutical Strategic Alliance Conference (PSA)

September 21-23, 2010 • New York
www.windhover.com

Bio-Europe Autumn 2010
14th Annual International Partnering Conference

November 15-17, 2010 • Munchen, Germany
www.ebdgroup.com/bioeurope